Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses

Seiffert, Moritz; Treede, Hendrik; Schöfer, Joachim; Linke, Axel; Wöehrle, Jochen; Baumbach, Hardy; Mehilli, Julinda; Bapat, Vinayak; Simonato, Matheus; Walther, Thomas; Kullmer, M.; Boekstegers, Peter; Ensminger, Stephan; Kurz, Thomas; Eltchaninoff, Hélène; Rastan, Ardawan; Werner, Nicolas; Weger, Arend de; Frerker, Christian; Lauer, Bernward; Müller, Olivier; Whisenant, Brian; Thukkani, Arun K.; Weisz, Giora; Dvir, Danny

doi:10.4244/eij-d-17-00546

Cited by 21 publications

(12 citation statements)

References 14 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A second analysis, comparing 514 SAPIEN XT and SAPIEN 3 patients, was able to identify a trend towards lower 30-day mortality in SAPIEN 3 cases (0.6% vs 3.5%) 16. These may reflect increased experience with balloon-expandable devices.…”

Section: Introductionmentioning

confidence: 91%

Transcatheter aortic valve replacement in failed surgical valves

Simonato

Dvir

2019

Heart

Self Cite

View full text Add to dashboard Cite

Aortic valve-in-valve is a less invasive alternative to surgical redo in the treatment of failed bioprosthetic valves. While only inoperable patients underwent the procedure before, operators currently offer it to those at lower risk and worldwide experience is in the thousands. Early mortality has diminished in recent analyses and improvements in symptoms and quality of life have been documented. Main considerations with aortic valve-in-valve include elevated postprocedural gradients, coronary obstruction and leaflet thrombosis. Risk factors for each of these adverse events have been described at length. Aortic valve-in-valve offers a safe and effective option in the management of failed bioprosthetic valves.

show abstract

Section: Introductionmentioning

confidence: 91%

Transcatheter aortic valve replacement in failed surgical valves

Simonato

Dvir

2019

Heart

Self Cite

View full text Add to dashboard Cite

show abstract

“…While several different transcatheter heart valves are currently available in the market, 22,23 the most widely used are the balloon-expandable SAPIEN 3 (Edwards Lifesciences) and the self-expandable Evolut (Medtronic Inc., Minneapolis, MN, USA). Each of these devices have specific advantages and disadvantages, and to date, no head-to-head prospective comparison in ViV has ever been performed.…”

Section: Select Optimal Transcatheter Heart Valve For Your Particularmentioning

confidence: 99%

The Ten Commandments of Aortic Valve-in-Valve

Simonato

Dvir

2020

Innovations�(Phila)

Self Cite

View full text Add to dashboard Cite

“…42,43 Dvir and colleagues recommend an optimum depth of 3 mm for the Medtronic Evolut SE valve and 80% aortic/20% ventricular deployment for a Edwards Sapien 3 BE valve. 45,46…”

Section: Postoperative Residual Gradientsmentioning

confidence: 99%

Valve-in-Valve TAVR: State-of-the-Art Review

Edelman

Khan

Rogers

et al. 2019

Innovations�(Phila)

View full text Add to dashboard Cite

An increasing number of surgically implanted bioprostheses will require re-intervention for structural valve deterioration. Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) has become an alternative to reoperative surgery, currently approved for high-risk and inoperable patients. Challenges to the technique include higher rates of prosthesis–patient mismatch and coronary obstruction, compared to native valve TAVR. Herein, we review results of ViV TAVR and novel techniques to overcome the aforementioned challenges.

show abstract

Matched comparison of next- and early-generation balloon-expandable transcatheter heart valve implantations in failed surgical aortic bioprostheses

Abstract: Transcatheter aortic VinV with the balloon-expandable SAPIEN XT or SAPIEN 3 was similarly safe and effective. However, residual stenosis remains a concern, particularly in smaller bioprostheses and with increasing implantation depth.

Cited by 21 publications

References 14 publications

Transcatheter aortic valve replacement in failed surgical valves

Transcatheter aortic valve replacement in failed surgical valves

The Ten Commandments of Aortic Valve-in-Valve

Valve-in-Valve TAVR: State-of-the-Art Review

Contact Info

Product

Resources

About